Finance III: From series A to IPO in 5 years
During the session, co-founder and CEO TimVan Hauwermeiren will mainly focus on key decisions which shaped the company and the lessons learned from an entrepreneur’s point of view.
Tim Van Hauwermeiren
Tim Van Hauwermeiren is co-founder and CEO of argenx NV. He has more than 20 years of general management and business development experience across the life sciences and fast moving consumer goods sectors.
At argenx NV and Ablynx NV he was involved in raising appr. EUR250 million, including 2 successful Euronext IPO’s, and in the deal making and alliance management with leading pharma companies including P&G Pharma, Novartis, Wyeth, Boehringer Ingelheim, Merck Serono, Eli Lilly, Shire, Bayer and LEO Pharma. Prior to joining the life sciences sector in 2003, he held various management positions with the Procter & Gamble Company in R&D and Business Development, where he conceived and developed several new products. Among those was a PUR® drinking water innovation which won the United Nations ICC World Business Award in 2004.
Tim Van Hauwermeiren holds a Master of Science in Bio-engineering from the University of Gent (Belgium) and received general management training at INSEAD (F) and The Vlerick School of Management (Executive MBA, Belgium).
Jumpstart your career
Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be organised from 24-28 June 2019 in Amsterdam, the Netherlands.
The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.